Ultrasound stimulation of the eye for vision restoration
Part of Eyes & vision, Genetic & congenital clinical trials.
This study tests a new, non-invasive treatment that uses ultrasound to stimulate the retina, with the goal of restoring some vision in people who have AMD or retinitis pigmentosa. It might help improve your sight without surgery or injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have age-related macular degeneration (AMD) or retinitis pigmentosa (RP).
- You must be 18 years old or older.
- You must not have any other eye conditions.
- You must not have a history of allergy to ultrasound gel.
- You must not have severe nearsightedness (prescription of -6.00 or higher).
- You must not be pregnant or have optic nerve problems (like glaucoma or optic neuropathy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a new, very high-resolution and high-speed eye scan can be used for people with eye problems or for healthy volunteers. It may help doctors better “see” eye structures more clearly to guide care.
This trial tests a new type of electrical stimulation, called microcurrent therapy, to see if it can help people with a certain form of age-related macular degeneration (AMD) that is not the "wet" kind. The treatment is delivered through an eye patch-like device and may slow vision loss or improve function.
This research study tests a new camera technology that takes detailed pictures of the back of your eye (retina) to better understand eye diseases. Researchers want to compare images from people with eye conditions like diabetes-related eye disease, glaucoma, or age-related macular degeneration with healthy volunteers to see how the new imaging works.
This study tests a quick, noninvasive eye test that measures how well you see in the dark, which can be an early sign of dry AMD. Researchers want to see if the test relates to everyday tasks like reading or driving at night.
This trial tests a new treatment called Eyecyte-RPE™, made from special cells that support the retina. It is given as a single injection under the retina during eye surgery. The study aims to see if it can help people with advanced dry age-related macular degeneration (AMD) who have large areas of damage (geographic atrophy) in the center of their vision.
This study tests whether a single injection of umbilical cord stem cells around the eye can safely help slow or improve vision loss from retinitis pigmentosa, a genetic eye disease. It also checks how long any benefits might last, using regular eye tests and a quality-of-life survey.
Hear when a new Age-Related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.